MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-KR-03-0200906
Brunex Pharmaceuticals Private Limited
Brunex Pharmaceuticals Private Limited - pharma in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2022
₹13.32 Lakh
▼ 63% YoY
Net loss · FY 2022
₹5.54 Lakh
Net margin -41.6%
EBITDA · FY 2022
-₹5.02 Lakh
EBITDA margin -37.7%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
12 yrs
Est. 2014
Directors on board
5
As per MCA filings
Active GSTINs
1
GST registered
About Brunex Pharmaceuticals Private Limited
Data last updated:
Brunex Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 September 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U74900KA2014PTC076638. Its GSTIN is 29AAHCB5291L1Z4 (Karnataka).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sree Hari Deva and Siddesha Kathasandra Malleswaraswamy.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 641/17/1 Kodigehalli Main Road Sahakaranagar Kodigehalli Yelahanka, Bangalore, Karnataka, India – 560024.
As per the financials filed for FY 2022, the company reported a revenue of ₹13.32 Lakh, a decline of 63% compared to the previous year. For the same year it recorded a net loss of ₹5.54 Lakh (net margin -41.6%) and EBITDA of -₹5.02 Lakh (EBITDA margin -37.7%). Revenue has grown at a compounded annual rate (CAGR) of 25% over three years.
Brunex Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0200906). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74900KA2014PTC076638
Registration Number 076638
Incorporation Date 29 September 2014
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-KR-03-0200906
Key People
Daskhinamurthy Jayamala Additional Director Sree Hari Deva Director Veera Kumar Reddy Oleti Additional Director Recognitions & Rankings of Brunex Pharmaceuticals
Contact details
Brunex Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address641/17/1 Kodigehalli Main Road Sahakaranagar Kodigehalli Yelahanka, Bangalore, Karnataka, India – 560024
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Brunex Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Brunex Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Brunex Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Brunex Pharmaceuticals Private Limited, buy the company report.
Financials of Brunex Pharmaceuticals Private Limited
FY 2023 filings availableBrunex Pharmaceuticals Private Limited reported revenue of ₹13.32 Lakh (down 63% YoY) for FY 2022.
Revenue · FY 2022
₹13.32 Lakh ▼ 63%
Net loss · FY 2022
₹5.54 Lakh margin -41.6%
EBITDA · FY 2022
-₹5.02 Lakh margin -37.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 63%
3 years · compounded
▲ 25%
EBITDA CAGR growth
3 years · compounded
▼ 29%
5 years · compounded
▼ 151%
Revenue fell 63% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 25%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹5.02 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹5.54 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -37.7% | ||||
| Net Profit Margin | -41.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Brunex Pharmaceuticals Private Limited, buy the company report.
Board of directors of Brunex Pharmaceuticals Private Limited
Brunex Pharmaceuticals has 5 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Daskhinamurthy Jayamala Also directs: Samjaya Healthcare Limited | Additional Director | 17 Mar 2022 | 4 Years 7 Months | Current |
| Sree Hari Deva | Director | 29 Sep 2014 | 12 Years 0 Months | Current |
| Veera Kumar Reddy Oleti | Additional Director | 05 Mar 2022 | 4 Years 7 Months | Current |
| Bhaskar Erugandindla | Additional Director | 05 Mar 2022 | 4 Years 7 Months | Current |
| Siddesha Kathasandra Malleswaraswamy | Director | 29 Sep 2014 | 12 Years 0 Months | Current |
Auditor
Brunex Pharmaceuticals Private Limited is audited by VENKATACHALA RAGHAVENDRA & CO for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VENKATACHALA RAGHAVENDRA & CO | FY 2018 | 010125S |
Shareholding
The shareholding of Brunex Pharmaceuticals Private Limited is on record for FY 2018, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2018 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Brunex Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Brunex Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Brunex Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Brunex Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAHCB5291L1Z4 | Karnataka | Active | 11 Sep 2018 |
To see the full GST registrations and return filing status of Brunex Pharmaceuticals Private Limited, buy the company report.
Recent activity
Brunex Pharmaceuticals Private Limited has 7 board changes on record since 2014: 5 appointments and 2 cessations. The latest: Daskhinamurthy Jayamala was appointed as Additional Director on 17 Mar 2022.
AGM
Brunex Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Brunex Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore.
Appointed
Daskhinamurthy Jayamala was appointed as Additional Director.
Ceased
Mallikarjun Chandrashekar Bidari ceased to be Director.
Appointed
Bhaskar Erugandindla was appointed as Additional Director.
Appointed
Veera Kumar Reddy Oleti was appointed as Additional Director.
Ceased
Joseph Henry Brown ceased to be Director.
Appointed
Siddesha Kathasandra Malleswaraswamy was appointed as Director.
Appointed
Sree Hari Deva was appointed as Director.
Incorporation
29 Sep 2014
Brunex Pharmaceuticals Private Limited was registered on 29 Sep 2014 with Roc Bangalore & aged 12 years 25 days as per MCA records.
Frequently asked questions
Brunex Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 September 2014 (12+ years old) and is registered under CIN U74900KA2014PTC076638.
Brunex Pharmaceuticals has 5 current directors:
- Daskhinamurthy Jayamala - Additional Director
- Sree Hari Deva - Director
- Veera Kumar Reddy Oleti - Additional Director
- Bhaskar Erugandindla - Additional Director
- Siddesha Kathasandra Malleswaraswamy - Director
The latest financial statements of Brunex Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Brunex Pharmaceuticals is 29AAHCB5291L1Z4, registered in Karnataka.
The CIN (Corporate Identification Number) of Brunex Pharmaceuticals is U74900KA2014PTC076638. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Brunex Pharmaceuticals was incorporated on 29 September 2014, making it 12+ years old. It is registered with the Registrar of Companies, Bangalore.
Daskhinamurthy Jayamala was appointed as Additional Director on 17 Mar 2022. Mallikarjun Chandrashekar Bidari ceased to be Director on 10 Mar 2022. Bhaskar Erugandindla was appointed as Additional Director on 05 Mar 2022. Brunex Pharmaceuticals has 7 board changes on record in total.
Yes, Brunex Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0200906).
The registered office of Brunex Pharmaceuticals is at 641171 Kodigehalli Main Road Sahakaranagar Kodigehalli Yelahanka, Bangalore, Karnataka, India – 560024.
Brunex Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.